Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of AdCh63 ME-TRAP and MVA ME-TRAP malaria vaccination in Gambian infants
PACTR201401000363170Completed
- Sponsor
- University of Oxford
- Start
- Sep 2011
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of ChAd63 ME-TRAP and MVA ME-TRAP in malaria (2 arms), sponsored by University of Oxford. Primary endpoint: Safety of heterologous prime-boost malaria vaccination. Started Sep 2011; status: completed.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201401000363170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201401000363170.